Barclays: Chips and Pharmaceutical Tariffs to Become the Next Battlefield Barclays economists stated in a report that the focus will now shift to the next specific product tariffs that US President Trump considers crucial for the US, particularly semiconductors and pharmaceuticals. This could have significant economic impacts on emerging Asian economies. Semiconductors are a more critical pressure point in the region. Although a specific implementation date for chip tariffs has not been announced, Barclays expects Malaysia to be the most vulnerable in this area. Barclays also noted that potential tariffs on the pharmaceutical industry could significantly affect Singapore. Pharmaceuticals account for a large portion of US imports from India, but overall, India's exposure in this regard is relatively limited.

Joseph Abate, senior strategist at Barclays, said in a report released this week that after the initial wave of runs following the bankruptcy of Silicon Valley Bank, a more sustained wave of deposit outflows may be imminent.

Following Barclays Plc, Goldman Sachs Group Inc. also advised clients in its latest report not to hold out hope that the Federal Reserve will cut interest rates this year.

Strategists at Barclays and JPMorgan have recently expressed their bearish views on the housing sector.

Barclays Capital said in a report on Thursday that the price of Brent crude oil is expected to be $89/barrel in the second quarter of this year.

Barclays sees the yen regaining its preeminent safe-haven status after years of dollar dominance as the Bank of Japan normalizes policy and the inflation shock recedes.